Effectiveness of Gene Editing in Human Stem Cells Improves Tenfold Using New Technique
For the first time, researchers have employed a gene-editing technique involving low-dose irradiation to edit the genome of patient stem cells, according to a study published in the journal Stem Cells Translational Medicine. This method, developed by researchers in the Cedars-Sinai Board of Governors Regenerative Medicine Institute, is 10 times more effective than techniques currently in use.
“This novel technique allows for far more efficient gene editing of stem cells and will increase the speed of new discoveries in the field,” said co-senior author Clive Svendsen, PhD, director of the Board of Governors Regenerative Medicine Institute.
The irradiation method could prove effective in learning more about diseases such as spinal muscular atrophy, muscular dystrophy and Huntington’s disease. Gene editing allows scientists to correct disease causing mutations and, theoretically, cure the disease in the petri dish. Additionally, gene-editing technology allows scientists to create disease mutations in normal cells, thus modeling human disease.
When using this form of gene editing, Cedars-Sinai scientists can more efficiently insert reporter genes that glow when a stem cell turns into a specific cell of the body. For example, stem cells would turn green when converted into a heart cell and red when turned into a neuron.
“The combination of low-dose irradiation and correct gene copy will accelerate our ability to model human disease using stem cells from patients with many different disorders,” said co-senior author Vaithilingaraja Arumugaswami, MVSc, PhD, director of the Pancreas and Liver Program in the Cedars-Sinai Board of Governors Regenerative Medicine Institute.
Over the past few years, the field of creating human diseases in the dish using stem cells has expanded rapidly. This work allows scientists to test novel drugs on human cells that carry disease-causing genes.
“Radiation, which is normally considered harmful, has proven beneficial in gene editing,” said Svendsen. This new technique will help us establish far more accurate models and accelerate the discovery process.”.
The Latest on: Gene Editing
via Google News
The Latest on: Gene Editing
- Gene-Therapy Treatments for Tay-Sachs, Sickle Cell, Other Diseases to Be Featured in Online Gatheringon May 12, 2020 at 9:40 am
This week’s online annual meeting of the American Society for Gene and Cell Therapy will take place on the web.
- MilliporeSigma Awarded 2 U.S. Patents toward CRISPR-Cas9-Assisted Genome Editingon May 12, 2020 at 6:46 am
MilliporeSigma said it has been granted two U.S. patents toward CRISPR-Cas9-assisted genome-editing, the third and fourth patents awarded to the company in the U.S.
- Intellia employs novel gene editing approach to improve AML candidateon May 12, 2020 at 5:21 am
(NASDAQ:NTLA) announces that its novel CRISPR/Cas9 gene editing approach has significantly improved the potential of T cell therapy candidate NTLA-5001 to introduce nucleic acid ...
- FDA Oks COVID Test Using Gene-Editing Technologyon May 11, 2020 at 11:22 am
The FDA has granted emergency use authorization for a coronavirus-detection test that uses CRISPR gene-editing technology.
- Gene therapy cuts fat and builds muscle in sedentary mice on unhealthy dietson May 11, 2020 at 5:55 am
A single injection of the gene that makes the protein follistatin caused a significant buildup of muscle mass in mice while also preventing obesity, reported Washington University researchers. The ...
- Dyno Debuts With Plan, Partnerships for Better Gene Therapy Vectorson May 11, 2020 at 4:04 am
Gene therapies deliver healthy genetic material to patients’ cells to replace a mutated, disease-causing variant. Dyno Therapeutics aims to create better ...
- Does gene editing hold key to better healthcare?on May 9, 2020 at 5:53 am
So, what is gene editing? This medical innovation, also called genome editing or gene engineering, involves the use of biotechnological methods to alter the genetic makeup of animals or plants with ...
- First-ever coronavirus test that uses gene-editing tool CRISPR that glows when the virus is detected and gives results in just one hour is approved by FDAon May 8, 2020 at 8:11 am
The new coronavirus test uses a CRISPR molecule that can find viral RNA instead of human DNA, in nose and throat samples, and glows when it's been found due to a fluorescent marker.
- Cambridge biotech’s virus test using CRISPR gene editing OK’d for crisison May 7, 2020 at 5:27 pm
Initially, Sherlock plans to initially sell enough tests for hospital laboratories to check at least 10,000 patients a week for the coronavirus. The company could ultimately do a million tests a week ...
- FDA OK’s first-ever use of gene-editing tool CRISPR to tackle Covid-19on May 7, 2020 at 7:00 am
This is an absolutely historic moment for biotech and healthcare, in that CRISPR has come of age," Sherlock Biosciences CEO told the Business Journal. A new diagnostic test is reportedly 100% accurate ...
via Bing News